Pharma Finance 2005

Rome, Italy - June 23-24, 2005

A unique two-day intensive approach to find and to offer, in an international environment: AIC, Patents & Licensing, Co-Marketing of Pharmaceuticals and Nutraceuticals.

Pharma Finance 2005 is not an arena-style conference. It is specifically designed to support in-depth partnership development and is therefore, by invitation only and limited to twelve presenting companies.

Biotech and pharmaceutical companies that are engaged in pursuing growth are given the opportunity to develop new contacts and to interact with representatives focusing on emerging adn established technologies. Companies from cutting edge, innovative research vehicles to life-enhancing product pipelines represent and array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. The event will expose companies to institutional investors, venture capitalists, senior corporate executives and experts from the scientific and medical communities.

40 % Biotech & Biopharma

A sizable portion of the audience are members of the European biotech industry like NOVARTIS - SIGMA - TAUE - MERK - PROCTOR & GAMBLE - SIENA BIOTEC plus many others. These attendees are looking for potential licensing deals or partnerships with our conference presenters.

20 % Lawfirms & Consulting

Some of the top lawfirms and consulting entities like MANZATO & ASSOCIATI - MORADINI & ASSOCIATI - INTERNATIONAL PHARMACHIM - MEDEPHA plus several others attend our conferences to help our presenters.

40 % Investors & Venture Capital

As large as the Biotech presence are the European investors like UBS - AFFI - ALBERINI SYZ - ANIMA - OPERA - SCHRODERS - ARCA MERCHANT plus many others. These invited attendees and European partners are looking for American/Foreign investments, especially in undervalued companies.